Llwytho...
Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
Non-valvular atrial fibrillation is becoming more common in Australia and globally The direct oral anticoagulants apixaban, dabigatran and rivaroxaban offer an improved safety profile over warfarin Patient preferences are important and shared decision-making supports better adherence to treatment
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Aust Prescr |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
NPS MedicineWise
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8075749/ https://ncbi.nlm.nih.gov/pubmed/33911332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18773/austprescr.2021.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|